TD Cowen Reaffirms $509 Price Target on Tesla
TD Cowen analyst Itay Michaeli reiterated a Buy rating and $509 price target on Tesla.
“We hosted a Mobility Bus tour in Austin last week, including visits to Tesla and Mobileye.
One common thread from our trip is that rapid AV scaling in the coming years has become a question of when, not if.
We walked away from our Tesla visit with added conviction in our Buy thesis.
We hosted a tour of Giga Texas, experienced FSD rides (including V14) and met with the IR team.
We walked away with added conviction in our Buy-thesis.
Top 3 takeaways:
(1) FSD rides were smooth & impressive.
(2) We gained greater appreciation for the degree of manufacturing innovation going into Cybercab.
We see a path for Cybercab to achieve a ~ $0.30 RoboTaxi cost/mile, below the $0.38 we previously modeled, allowing Tesla to offer AV trips at a price/mile that competes with personal mobility.
By our estimates, every 5% US VMT penetration in just the low/mid-population dense MSAs (i.e. arguably easier deployments) could unlock a ~$100bln revenue opportunity at $1/mile.
We regard the Apr 2026 Cybercab SoP as a sign of Tesla’s confidence in scaling RoboTaxis on HW4, and believe a successful ramp could result in a step-function change in Tesla’s revenue growth outlook, with AVs expected to become financially material contributors in H2’26.
(3) Significant SW improvement still exists on HW4, with V14 expected to achieve a 10x parameter count.
Tesla’s strong SW/HW integration will be further leveraged with AI5/6.”
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.
This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.


